Patrick J. Marshalek , MD

Associate Professor

Organization:

West Virginia University School of Medicine

Department:

Department of Neuroscience

Classification:

Faculty

• MD, West Virginia University, 2006

Zheng, W., Nickasch, M., Lander, L., Wen, S., Xiao, M., Marshalek, P., Dix, E, Sullivan, C. (2017). Treatment Outcome Comparison between Telepsychiatry and Face-to-face Buprenorphine Medication-Assisted Treatment (MAT) for Opioid Use Disorder: A 2-Year Retrospective Data Analysis. Journal of Addiction Medicine, 11(2), 138–144. http://doi.org/10.1097/ADM.0000000000000287

Nguyen L, Lander LR, O'Grady KE, Marshalek PJ, Schmidt A, Kelly AK, Jones HE. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure. Am J Addict. 2018 Mar;27(2):92-96. doi: 10.1111/ajad.12687. Epub 2018 Feb 23. https://www.ncbi.nlm.nih.gov/pubmed/29473258

Wilson A, Marshalek P.  Drugs and Alcohol.  TRAUMA. Editors: Mattox KL, Moore EE, Feliciano DV.  McGraw-Hill, New York, NY. May 24, 2017 (ISBN 9781260128604)

Haut MW, Hogg JP, Marshalek PJ, Suter BC, Miller LE. Amnesia Associated with Bilateral Hippocampal and Bilateral Basal Ganglia Lesions in Anoxia with Stimulant Use. Front Neurol. 2017 Feb 8;8:27. doi: 10.3389/fneur.2017.00027. eCollection 2017. PMID: 28228745 https://www.ncbi.nlm.nih.gov/pubmed/28228745

Zheng W, Nickasch M, Lander L, Wen S, Xiao M, Marshalek P, Dix E, Sullivan C. Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis. J Addict Med. 2017 Mar/Apr;11(2):138-144. doi: 10.1097/ADM.0000000000000287. PMID: 28107210

Shenai N, Glance J, Marshalek P. Special Interest Groups-Updates in Psychosomatics (SIG-UPs): Alcohol Use Disorders in Women. Psychosomatics. 2017 Jan - Feb;58(1):91-92. doi: 10.1016/j.psym.2016.08.008. Epub 2016 Aug 20. No abstract available. PMID: 28010750

Nguyen, L, Marshalek, P J, Weaver, C B, Cramer, K J, Pollard, SE, Matsumoto, RR. Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review. Neuropsychiatric Disease and Treatment. 2015; 11:2667-2673. doi: 10.2147/NDT. S88569. 

Lander L, Gurka K, Marshalek P, Riffon M, Sullivan R. Treatment of Pregnant Women With Opioid Use Disorders on Buprenorphine in Pregnancy-Only vs. Mixed-Gender Groups, submitted to SW Research, (2015) 39 (4): 235-244. 

 

HONORS/AWARDS

Outstanding Faculty Award - 2012

Honoring the faculty whose efforts embody the principles of an academic institution in the furthering of resident growth and development as selected by the Psychiatry Residents.

Chairman’s Commonwealth Award - 2013

Honoring a faculty, resident or staff member whose commitment to the department has benefited others and whose efforts have made significant contribution across many domains to the well-being of the department.

Chairman’s Research Award - 2016

Presented to a deserving faculty member for research productivity as demonstrated through development, grantsmanship, innovation, education, publication, or presentations.

Dorfman Journal Paper Award - 2016

For Best Review Article - Psychosomatics, “Guidelines for the Management of Pregnant Women with Substance Use Disorders.”

Dr. Patrick J. Marshalek is a Psychiatrist who practices Chronic Pain Management and Psychiatry within the School of Medicine of West Virginia University. Dr. Marshalek’s primary appointment is in the Department of Behavioral Medicine and Psychiatry.  Dr. Marshalek received a joint appointment with the Department of Anesthesiology in August 2015. He is currently an Associate Professor. 

Dr. Marshalek provides inpatient and outpatient services at both Ruby Memorial Hospital and Chestnut Ridge Hospital.  He is the medical director for Electroconvulsive Therapy (ECT), RMH Psychiatry consults, and RMH Pain Research Management.  Dr. Marshalek is the Chair of the Behavioral Medicine/Emergency Department Relations Committee.  He is the co-director the RMH Pain Committee and is a member of the Department of BM&P Promotion and Tenure Committee, Resident Recruitment Committee, and the CRH QI Committee. He has recently assumed Directorship of the Geriatric Unit.

Dr. Marshalek is the Assertive Community Treatment Medical Director and has contributed significantly to the Comprehensive Opiod Addiction Treatment Clinic through work with Pregnancy COAT, General COAT, and by providing telemedicine services to increase healthcare access.  Dr. Marshalek serves as the Thread Director for the Curriculum Committee at WVU School of Medicine, and through this is helping to train medical students in appropriate opioid prescribing practices in accordance with the new CDC guidelines.

RESEARCH EXPERIENCE/GRANTS

The Use of Ketamine in Treatment Resistant Depression

• Funding: Department of Behavioral Medicine & Psychiatry
• Award Amount: $5,000
• Contribution: Principal Investigator

Feasibility and Function of using Audience Response System in a Clinical Setting with Pregnant Patients with Opioid Use Disorder

• Funding: Department of Behavioral Medicine & Psychiatry
• Award Amount: $6,850
• Contribution: Co-Investigator

Drug Free Mom’s and Babies                                          

• Funding: The West Virginia Perinatal Partnership and The Benedum Foundation
• Award Amount:  $90,000                
• Contribution:  Co-Investigation

 

Medical Specialties

• Behavioral Medicine and Psychiatry

Board Certifications

• Psychiatry, American Board of Psychiatry and Neurology

Special Training

• Residency, Psychiatry
  West Virginia University Hospitals, 2010